201 related articles for article (PubMed ID: 16143118)
21. Identification of a peptide from alpha-gliadin resistant to digestive enzymes: implications for celiac disease.
Mamone G; Ferranti P; Rossi M; Roepstorff P; Fierro O; Malorni A; Addeo F
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):236-41. PubMed ID: 17544966
[TBL] [Abstract][Full Text] [Related]
22. Papaya latex enzymes capable of detoxification of gliadin.
Cornell HJ; Doherty W; Stelmasiak T
Amino Acids; 2010 Jan; 38(1):155-65. PubMed ID: 19156482
[TBL] [Abstract][Full Text] [Related]
23. Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease.
Esposito G; Cirillo C; Sarnelli G; De Filippis D; D'Armiento FP; Rocco A; Nardone G; Petruzzelli R; Grosso M; Izzo P; Iuvone T; Cuomo R
Gastroenterology; 2007 Sep; 133(3):918-25. PubMed ID: 17678654
[TBL] [Abstract][Full Text] [Related]
24. Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity.
Hollon J; Puppa EL; Greenwald B; Goldberg E; Guerrerio A; Fasano A
Nutrients; 2015 Feb; 7(3):1565-76. PubMed ID: 25734566
[TBL] [Abstract][Full Text] [Related]
25. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
26. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.
de Ritis G; Auricchio S; Jones HW; Lew EJ; Bernardin JE; Kasarda DD
Gastroenterology; 1988 Jan; 94(1):41-9. PubMed ID: 3335296
[TBL] [Abstract][Full Text] [Related]
27. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
[TBL] [Abstract][Full Text] [Related]
28. Structural analysis and Caco-2 cell permeability of the celiac-toxic A-gliadin peptide 31-55.
Iacomino G; Fierro O; D'Auria S; Picariello G; Ferranti P; Liguori C; Addeo F; Mamone G
J Agric Food Chem; 2013 Feb; 61(5):1088-96. PubMed ID: 23298305
[TBL] [Abstract][Full Text] [Related]
29. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.
Di Sabatino A; Pickard KM; Gordon JN; Salvati V; Mazzarella G; Beattie RM; Vossenkaemper A; Rovedatti L; Leakey NA; Croft NM; Troncone R; Corazza GR; Stagg AJ; Monteleone G; MacDonald TT
Gastroenterology; 2007 Oct; 133(4):1175-87. PubMed ID: 17919493
[TBL] [Abstract][Full Text] [Related]
30. Gliadin-dependent cytokine production in a bidimensional cellular model of celiac intestinal mucosa.
Vincentini O; Maialetti F; Gonnelli E; Silano M
Clin Exp Med; 2015 Nov; 15(4):447-54. PubMed ID: 25447031
[TBL] [Abstract][Full Text] [Related]
31. Impact of food processing and simulated gastrointestinal digestion on gliadin immunoreactivity in rolls.
Brzozowski B
J Sci Food Agric; 2018 Jul; 98(9):3363-3375. PubMed ID: 29277903
[TBL] [Abstract][Full Text] [Related]
32. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease.
Liu E; Li M; Emery L; Taki I; Barriga K; Tiberti C; Eisenbarth GS; Rewers MJ; Hoffenberg EJ
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):293-300. PubMed ID: 17873740
[TBL] [Abstract][Full Text] [Related]
33. Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides.
Auricchio S; De Ritis G; De Vincenzi M; Magazzù G; Maiuri L; Mancini E; Minetti M; Sapora O; Silano V
Gastroenterology; 1990 Oct; 99(4):973-8. PubMed ID: 2394351
[TBL] [Abstract][Full Text] [Related]
34. Conjugated linoleic acid protects against gliadin-induced depletion of intestinal defenses.
Bergamo P; Gogliettino M; Palmieri G; Cocca E; Maurano F; Stefanile R; Balestrieri M; Mazzarella G; David C; Rossi M
Mol Nutr Food Res; 2011 Sep; 55 Suppl 2():S248-56. PubMed ID: 21954188
[TBL] [Abstract][Full Text] [Related]
35. In vitro digestive stability of complexes between gliadin and synthetic blocking peptides.
Hoffmann K; Carlsson NG; Alminger M; Chen T; Wold A; Olsson O; Sandberg AS
Biotechnol Appl Biochem; 2011 May; 58(3):190-7. PubMed ID: 21679243
[TBL] [Abstract][Full Text] [Related]
36. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.
Stepniak D; Spaenij-Dekking L; Mitea C; Moester M; de Ru A; Baak-Pablo R; van Veelen P; Edens L; Koning F
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G621-9. PubMed ID: 16690904
[TBL] [Abstract][Full Text] [Related]
37. Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease.
Mitea C; Havenaar R; Drijfhout JW; Edens L; Dekking L; Koning F
Gut; 2008 Jan; 57(1):25-32. PubMed ID: 17494108
[TBL] [Abstract][Full Text] [Related]
38. A methacrylic hyaluronic acid derivative for potential application in oral treatment of celiac disease.
Pitarresi G; Palumbo FS; Triolo D; Fiorica C; Giammona G
Drug Dev Ind Pharm; 2017 Sep; 43(9):1480-1488. PubMed ID: 28406045
[TBL] [Abstract][Full Text] [Related]
39. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone in celiac intestinal mucosa.
Colombo G; Buffa R; Bardella MT; Garofalo L; Carlin A; Lipton JM; Catania A
Neuroimmunomodulation; 2002-2003; 10(4):208-16. PubMed ID: 12584408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
